Insider Buying in Heron Therapeutics, Inc. (HRTX)

On Oct. 4, 2019, Kevin Tang – Director of Heron Therapeutics, Inc. (HRTX) – purchased 285,714 shares of HRTX at $17.5. The cost was $4,999,995.